Description
The Defense Logistics Agency (DLA) is issuing a fully‑competitive, firm‑fixed‑price, requirements‑type contract for Epinephrine 0.3 mg/0.3 ml auto‑injectors (2‑count boxes). The contract will be a one‑year base period with four optional one‑year extensions (up to five years total). It will establish a national supply source for DoD, VA, Indian Health Service, and Bureau of Prisons customers. Offerors must submit electronic proposals via the DLA Internet Bid Board System (DIBBS) between October 1 and November 2 2026. The solicitation includes a reverse‑auction provision that may be activated after offers are received. A subcontracting plan is required for large‑business offerors expected to exceed $900 K. The award will be made to the lowest priced technically acceptable source, subject to applicable FAR and DFARS clauses.
• 0.3 mg/0.3 ml Epinephrine auto‑injector, 2‑count box (commercial item)
• Firm‑fixed‑price, requirements contract (base year + 4 options)
• Nationwide supply for multiple federal agencies (DoD, VA, IHS, BOP)
• Submission via DIBBS only; opening Oct 1 2026, closing Nov 2 2026 3 PM ET
• Potential reverse‑auction; large‑business subcontracting plan required
• Estimated annual quantity ≈ 473,905 boxes (per schedule)